News

Presentations at Stanford Biodesign New Arrhythmia Technologies Retreat and Heart Rhythm Society (HRS) Continue Focus on Atrial Fibrillation Ablation CardioFocus, Inc., developer of the HeartLight® Endoscopic Ablation System for the...

Current and Future Uses Highlighted in First-Time Session Technology’s newest tool — and its potential to improve patient care — will be the focus of a first-of-its-kind special session at the SCAI 2014 Scientific Sessions in Las Vegas,...

The decision follows a successful trial period where the automated inventory management system installed monitors the stock usage, and sends the reordering data to both the hospital and vendor Month April 24th, 2014 – LogiTag Systems, a...

First Patient Enrolled in U.S. Pivotal Clinical Trial to Evaluate the Evera MRI(TM) ICD System Medtronic announced the first U.S. implant of the Evera MRI(TM) SureScan® implantable cardioverter-defibrillator (ICD) System, following U.S. Food...

Boston Scientific Corporation has conducted the first implant in the clinical trial of the next generation ACUITY™ X4 left-ventricular (LV) pacing leads and RELIANCE™ 4-FRONT defibrillation (ICD) leads. The clinical trial is designed to...

ARCA biopharma, Inc., a biopharmaceutical company developing genetically targeted therapies for cardiovascular diseases, announced that the first patient has been genetically screened in GENETIC-AF, its Phase 2B/3 adaptive design clinical...

Boston Scientific Corporation has received FDA approval for its latest generation of defibrillators and heart failure devices designed to advance patient care. The newly approved devices include the DYNAGEN™ MINI and INOGEN™ MINI ICDs, as...

Expands Cardiac Lead Extraction Portfolio to Include TightRail™ Rotating Mechanical Dilator Sheath and SightRail™ Manual Mechanical Dilator Sheath Set The Spectranetics Corporation announced FDA clearance of two new mechanical lead...

Landmark BLOCK HF Trial Demonstrates Clinical Benefits of Biventricular Pacing in New Patient Population Medtronic, Inc. announced that the U.S. Food and Drug Administration (FDA) approved an expanded indication for biventricular (BiV)...

CardioTek B.V. announced that it has received 510(k) clearance from the Food and Drug Administration (FDA) for its EP‐Tracer System (FDA Reference Number K134044). The EP‐Tracer System is an electrophysiology measurement system used to...